These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
466 related items for PubMed ID: 19670425
1. Experimental models for hepatitis C viral infection. Boonstra A, van der Laan LJ, Vanwolleghem T, Janssen HL. Hepatology; 2009 Nov; 50(5):1646-55. PubMed ID: 19670425 [Abstract] [Full Text] [Related]
2. HCV research and anti-HCV drug discovery: toward the next generation. Wakita T. Adv Drug Deliv Rev; 2007 Oct 10; 59(12):1196-9. PubMed ID: 17905463 [Abstract] [Full Text] [Related]
3. HCV-hepatocellular carcinoma: new findings and hope for effective treatment. Dash S, Haque S, Joshi V, Prabhu R, Hazari S, Fermin C, Garry R. Microsc Res Tech; 2005 Nov 10; 68(3-4):130-48. PubMed ID: 16276514 [Abstract] [Full Text] [Related]
4. Animal models for the study of hepatitis C virus infection and related liver disease. Bukh J. Gastroenterology; 2012 May 10; 142(6):1279-1287.e3. PubMed ID: 22537434 [Abstract] [Full Text] [Related]
5. Innate and adaptive immune responses in HCV infections. Heim MH, Thimme R. J Hepatol; 2014 Nov 10; 61(1 Suppl):S14-25. PubMed ID: 25443342 [Abstract] [Full Text] [Related]
6. Evaluation systems for anti-HCV drugs. Moriishi K, Matsuura Y. Adv Drug Deliv Rev; 2007 Oct 10; 59(12):1213-21. PubMed ID: 17720275 [Abstract] [Full Text] [Related]
7. In vitro replication models for the hepatitis C virus. Sheehy P, Mullan B, Moreau I, Kenny-Walsh E, Shanahan F, Scallan M, Fanning LJ. J Viral Hepat; 2007 Jan 10; 14(1):2-10. PubMed ID: 17212638 [Abstract] [Full Text] [Related]
8. [Molecular mechanisms of the hepatitis C virus, potential therapeutic targets]. Rivas-Estilla AM, Panduro A. Rev Invest Clin; 2003 Jan 10; 55(1):51-64. PubMed ID: 12708164 [Abstract] [Full Text] [Related]
9. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system. Zhu H, Dong H, Eksioglu E, Hemming A, Cao M, Crawford JM, Nelson DR, Liu C. Gastroenterology; 2007 Nov 10; 133(5):1649-59. PubMed ID: 17983809 [Abstract] [Full Text] [Related]
10. Experimental models to study the immunobiology of hepatitis C virus. Jo J, Lohmann V, Bartenschlager R, Thimme R. J Gen Virol; 2011 Mar 10; 92(Pt 3):477-93. PubMed ID: 21148278 [Abstract] [Full Text] [Related]
11. The hepatitis C virus life cycle as a target for new antiviral therapies. Pawlotsky JM, Chevaliez S, McHutchison JG. Gastroenterology; 2007 May 10; 132(5):1979-98. PubMed ID: 17484890 [Abstract] [Full Text] [Related]
12. Pathophysiology of hepatitis C virus infection. Camps J, Córdoba J, Esteban JI. Pathol Biol (Paris); 1995 Oct 10; 43(8):691-702. PubMed ID: 8745591 [Abstract] [Full Text] [Related]
13. A primer on the molecular virology of hepatitis C. Moradpour D, Blum HE. Liver Int; 2004 Dec 10; 24(6):519-25. PubMed ID: 15566499 [Abstract] [Full Text] [Related]
19. The hepatitis C virus (HCV)-Trimera mouse: a model for evaluation of agents against HCV. Ilan E, Arazi J, Nussbaum O, Zauberman A, Eren R, Lubin I, Neville L, Ben-Moshe O, Kischitzky A, Litchi A, Margalit I, Gopher J, Mounir S, Cai W, Daudi N, Eid A, Jurim O, Czerniak A, Galun E, Dagan S. J Infect Dis; 2002 Jan 15; 185(2):153-61. PubMed ID: 11807688 [Abstract] [Full Text] [Related]
20. Cell culture models and animal models of viral hepatitis. Part II: hepatitis C. Guha C, Lee SW, Chowdhury NR, Chowdhury JR. Lab Anim (NY); 2005 Feb 15; 34(2):39-47. PubMed ID: 15685191 [Abstract] [Full Text] [Related] Page: [Next] [New Search]